Overview

Lethargic Depression Study

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
This is a study of Major Depressive Disorder (MDD) in patients with decreased energy, pleasure and interests.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Bupropion